[Prevention of anxiety syndrome in antihistamine body therapy].
D018926:Anti-Allergic Agents; D001007:Anxiety / Q000209:etiology*; D001008:Anxiety Disorders; D006634:Histamine H1 Antagonists / Q000009:adverse effects*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives
ANTIHISTAMINICS/injurious effects; ANXIETY/etiology and pathogenesis; HYPNOTICS AND SEDATIVES/therapeutic use
Verhinderung des Angstsyndroms bei Antihistaminkörper-Therapie.